Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward

Clinical Infectious Diseases

Volumn 62, Issue , 2016, Pages S91-S95

  Parashar, Umesh D ^a   Johnson, Hope ^b   Steele, A Duncan ^c   Tate, Jacqueline E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b GAVI Alliance   (Switzerland)

^c BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

developing countries; effectiveness; impact; rotavirus; rotavirus vaccines

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; DEVELOPING COUNTRY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; HEALTH IMPACT ASSESSMENT; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK REDUCTION; VACCINATION; VIRAL GASTROENTERITIS; WORLD HEALTH ORGANIZATION; AUSTRALIA; COST BENEFIT ANALYSIS; EUROPE; GASTROENTERITIS; IMMUNOLOGY; POVERTY; PREVENTIVE HEALTH SERVICE; ROTAVIRUS INFECTIONS; STATISTICS AND NUMERICAL DATA; TRENDS; VIROLOGY;

AUSTRALIA; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; EUROPE; GASTROENTERITIS; HEALTH IMPACT ASSESSMENT; HUMANS; IMMUNIZATION PROGRAMS; POVERTY; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 84965147086     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ1015     Document Type: Article

References (48)

1. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33.
2. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22.
3. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999; 48:1007.
4. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine-United States, 1998-1999. MMWR Morb Mortal Wkly Rep 1999; 48:577-81.
5. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001; 344:564-72.
6. Peter G, Myers MG; National Vaccine Advisory Committee, National Vaccine Program Office. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics 2002; 110:e67.
7. Conclusions and recommendations from the Immunization Strategic Advisory Group. Wkly Epidemiol Rec 2006; 81:2-11.
8. PatelMM, Glass R, Desai R, Tate JE, Parashar UD. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? Lancet Infect Dis 2012; 12:561-70.
9. Yen C, Tate JE, Wenk JD, Harris JM 2nd, Parashar UD. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction. Pediatrics 2011; 127:e9-15.
10. Cortese MM, Tate JE, Simonsen L, Edelman L, Parashar UD. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J 2010; 29:489-94.
11. Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011; 204:980-6.
12. Gastanaduy PA, Curns AT, Parashar UD, Lopman BA. Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination. JAMA 2013; 310:851-3.
13. Paulke-Korinek M, Kundi M, Rendi-Wagner P, et al. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine 2011; 29:2791-6.
14. Raes M, Strens D, Vergison A, Verghote M, Standaert B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J 2011; 30:e120-5.
15. Hemming M, Rasanen S, Huhti L, Paloniemi M, Salminen M, Vesikari T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr 2013; 172:739-46.
16. Field EJ, Vally H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010; 126: e506-12.
17. Clarke MF, Davidson GP, Gold MS, Marshall HS. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine 2011; 29:4663-7.
18. Yen C, Armero Guardado JA, Alberto P, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011; 30(1 suppl):S6-10.
19. Safadi MA, Berezin EN, Munford V, et al. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in Sao Paulo, Brazil. Pediatr Infect Dis J 2010; 29:1019-22.
20. do Carmo GM, Yen C, Cortes J, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: A time-series analysis. PLoS Med 2011; 8:e1001024.
21. Lanzieri TM, Linhares AC, Costa I, et al. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. Int J Infect Dis 2011; 15:e206-10.
22. Richardson V, Parashar U, Patel M. Childhood diarrhea deaths after rotavirus vaccination in Mexico. N Engl J Med 2011; 365:772-3.
23. Gastanaduy PA, Sanchez-Uribe E, Esparza-Aguilar M, et al. Effect of rotavirus vaccine on diarrhea mortality in different socioeconomic regions of Mexico. Pediatrics 2013; 131:e1115-20.
24. Bayard V, DeAntonio R, Contreras R, et al. Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama. Int J Infect Dis 2012; 16:e94-8.
25. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14.
26. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98.
27. Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: A randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:615-23.
28. Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009; 84:533-40.
29. Meeting of the Strategic Advisory Group of Experts on immunization, October 2009-conclusions and recommendations. Wkly Epidemiol Rec 2009; 84: 517-32.
30. Meeting of the immunization Strategic Advisory Group of Experts, April 2009- conclusions and recommendations. Wkly Epidemiol Rec 2009; 84:220-36.
31. Enane LA, Gastañaduy PA, Goldfarb DM, et al. Impact of rotavirus vaccination on hospitalizations and deaths from childhood gastroenteritis in Botswana. Clin Infect Dis 2016; 62(suppl 2):S168-74.
32. Groome MJ, Zell ER, Solomon F, et al. Temporal association of rotavirus vaccine introduction and reduction in all-cause childhood diarrheal hospitalizations in South Africa. Clin Infect Dis 2016; 62(suppl 2):S188-95.
33. Armah G, Pringle K, Enweronu-Laryea CC, et al. Impact and effectiveness of monovalent rotavirus vaccine against severe rotavirus diarrhea in Ghana. Clin Infect Dis 2016; 62(suppl 2):S200-7.
34. Tsolenyanu E, Mwenda JM, Dagnra A, et al. Early evidence of impact of monovalent rotavirus vaccine in Togo. Clin Infect Dis 2016; 62(suppl 2): S196-9.
35. Mpabalwani EM, Simwaka CJ, Mwenda JM, et al. Impact of rotavirus vaccination on diarrheal hospitalizations in children aged <5 years in Lusaka, Zambia. Clin Infect Dis 2016; 62(suppl 2):S183-7.
36. Sahakyan G, Grigoryan S,Wasley A, et al. Impact and effectiveness of monovalent rotavirus vaccine in Armenian children. Clin Infect Dis 2016; 62(suppl 2): S147-54.
37. Gheorghita S, Birca L, Donos S, et al. Impact of rotavirus vaccine introduction and vaccine effectiveness in the republic of Moldova. Clin Infect Dis 2016; 62(suppl 2): S140-6.
38. Sánchez-Uribe E, Esparza-Aguilar M, Parashar UD, Richardson V. Sustained reduction of childhood diarrhea-related mortality and hospitalizations in Mexico after rotavirus vaccine universalization. Clin Infect Dis 2016; 62(suppl 2):S133-9.
39. Pringle KD, Patzi M, Tate JE, et al. Sustained effectiveness of rotavirus vaccine against very severe rotavirus disease through the second year of life, Bolivia 2013-2014. Clin Infect Dis 2016; 62(suppl 2):S115-20.
40. Gastañaduy PA, Contreras-Roldán I, Bernart C, et al. Effectiveness of monovalent and pentavalent rotavirus vaccines in Guatemala. Clin Infect Dis 2016; 62(suppl 2):S121-6.
41. Gastañaduy PA, Steenhoff AP, Mokomane M, et al. Effectiveness of monovalent rotavirus vaccine after programmatic implementation in Botswana: A multisite prospective case-control study. Clin Infect Dis 2016; 62(suppl 2):S161-7.
42. Tate JE, Ngabo F, Donnen P, et al. Effectiveness of pentavalent rotavirus vaccine under conditions of routine use in Rwanda. Clin Infect Dis 2016; 62(suppl 2): S208-12.
43. Bar-Zeev N, Jere KC, Bennett A, et al. Population impact and effectiveness of monovalent rotavirus vaccination in urban Malawian children 3 years after vaccine introduction: ecological and case-control analyses. Clin Infect Dis 2016; 62(suppl 2): S213-9.
44. Leshem E, Givon-Lavi N, Tate JE, et al. Real-world effectiveness of pentavalent rotavirus vaccine among bedouin and Jewish children in Southern Israel. Clin Infect Dis 2016; 62(suppl 2):S155-60.
45. Patel M, Pedreira C, De Oliveira LH, et al. Effectiveness of pentavalent rotavirus vaccine against a diverse range of circulating strains in Nicaragua. Clin Infect Dis 2016; 62(suppl 2):S127-32.
46. Bhandari N, Rongsen-Chandola T, Bavdekar A, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: A randomised, double-blind, placebo-controlled trial. Lancet 2014; 383:2136-43.
47. Prime Minister of India Office. Available at: http://pmindia.gov.in/en/news-up dates/three-new-vaccines-including-indigenously-developed-rotavirus-vaccine-tobe-provided-to-all-indian-childrenfourth-vaccine-for-adults-to-protect-againstjapanese-encephalitis-to-be-introduced-in-high-p/. Accessed 2 October 2015.
48. Rotavirus vaccines. WHO position paper-January 2013. Wkly Epidemiol Rec 2013; 88:49-64.